CoChat

Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpoint

Open access
Staffaroni, Adam M., Bajorek, Lynn, Casaletto, Kaitlin B., Cobigo, Yann, Goh, Sheng‐Yang M., Wolf, Amy, Heuer, Hilary W., Elahi, Fanny M., Ljubenkov, Peter A., Dever, Reilly, Kornak, John, Appleby, Brian, Bove, Jessica, Bordelon, Yvette, Brannelly, Patrick, Brushaber, Danielle, Caso, Christina, Coppola, Giovanni, Dheel, Christina, Dickerson, Bradford C., Dickinson, Susan, Dominguez, Sophia, Domoto‐Reilly, Kimiko, Faber, Kelly, Ferrall, Jessica, Fields, Julie A., Fishman, Ann, Fong, Jamie, Foroud, Tatiana, Forsberg, Leah K., Gavrilova, Ralitza, Gearhart, Debra, Ghazanfari, Behnaz, Ghoshal, Nupur, Goldman, Jill, Graff‐Radford, Jonathan, Graff‐Radford, Neill, Grant, Ian, Grossman, Murray, Haley, Dana, Hsiung, Ging‐Yuek, Huey, Edward D., Irwin, David J., Jones, David T., Jones, Lynne, Kantarci, Kejal, Karydas, Anna, Kaufer, Daniel I., Kerwin, Diana R., Knopman, David S., Kraft, Ruth, Kremers, Walter K., Kukull, Walter A., Litvan, Irene, Lucente, Diane, Lungu, Codrin, Mackenzie, Ian R., Maldonado, Miranda, Manoochehri, Masood, McGinnis, Scott M., McKinley, Emily, Mendez, Mario F., Miller, Bruce L., Multani, Namita, Onyike, Chiadi, Padmanabhan, Jaya, Pantelyat, Alex, Pearlman, Rodney, Petrucelli, Len, Potter, Madeline, Rademakers, Rosa, Ramos, Eliana Marisa, Rankin, Katherine P., Rascovsky, Katya, Roberson, Erik D., Rogalski, Emily, Sengdy, Pheth, Shaw, Leslie M., Syrjanen, Jeremy, Tartaglia, M. Carmela, Tatton, Nadine, Taylor, Joanne, Toga, Arthur, Trojanowski, John Q., Weintraub, Sandra, Wang, Ping, Wong, Bonnie, Wszolek, Zbigniew, Boxer, Adam L., Boeve, Brad F., Kramer, Joel H., Rosen, Howard J., on behalf of the ARTFL/LEFFTDS consortium · 2020 · Alzheimer's & Dementia
Cited by 47

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Introduction: Identifying clinical measures that track disease in the earliest stages of frontotemporal lobar degeneration (FTLD) is important for clinical trials. Familial FTLD provides a unique paradigm to study early FTLD. Executive dysfunction is a clinically relevant hallmark of FTLD and may be a marker of disease progression. Methods: Ninety‐three mutation carriers with no symptoms or minimal/questionable symptoms (MAPT, n = 31; GRN, n = 28; C9orf72, n = 34; Clinical Dementia Rating scale plus NACC FTLD Module < 1) and 78 noncarriers enrolled through Advancing Research and Treatment in Frontotemporal Lobar Degeneration/Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects studies completed the Executive Abilities: Measures and Instruments for Neurobehavioral Evaluation and Research (NIH‐EXAMINER) and the UDS neuropsychological battery. Linear mixed‐effects models were used to identify group differences in cognition at baseline and longitudinally. We examined associations between cognition, clinical functioning, and magnetic resonance imaging volumes. Results: NIH‐EXAMINER scores detected baseline and differences in slopes between carriers and noncarriers, even in carriers with a baseline Clinical Dementia Rating scale plus NACC FTLD Module = 0. NIH‐EXAMINER declines were associated with worsening clinical symptoms and brain volume loss. Discussion: The NIH‐EXAMINER is sensitive to cognitive changes in presymptomatic familial FTLD and is a promising surrogate endpoint.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2019.01.012

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 24

  1. 10.1126/scitranslmed.3007941 · DOI · Paper page
  2. 10.1038/547153a · DOI · Paper page
  3. 10.1111/jnc.13640 · DOI · Paper page
  4. Mansoor Y, 2014, Memory Profiles in Pathology or Biomarker Confirmed Alzheimer Disease and Frontotemporal Dementia, Alzheimer Dis Assoc Disord, 29, 135, 10.1097/WAD.0000000000000062 · DOI · Paper page
  5. 10.1097/00146965-200312000-00002 · DOI · Paper page
  6. Patel AN, 2015, Cognitive Profile of C9orf72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis, Curr Neurol Neurosci Rep, 15, 59, 10.1007/s11910-015-0582-9 · DOI
  7. 10.1212/WNL.0b013e318296e940 · DOI · Paper page
  8. 10.1177/0891988717700507 · DOI
  9. 10.1016/S1353-8020(02)00098-6 · DOI
  10. 10.1002/ana.10024 · DOI · Paper page
  11. 10.1017/S1355617713001094 · DOI · Paper page
  12. Weintraub S, 2017, Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS), Alzheimer Dis Assoc Disord, 1
  13. 1944, Army Individual Test Battery Manual of Directions and Scoring
  14. Delis DC, 2000, California Verbal Learning Test - second edition. Adult version. Manual
  15. 10.1016/j.jalz.2016.10.006 · DOI · Paper page
  16. Sakpal TV, 2010, Sample size estimation in clinical trial, Perspect Clin Res, 1, 67, 10.4103/2229-3485.71856 · DOI · Paper page
  17. Possin KL, 2018, Ecological Validity and Neuroanatomical Correlates of the NIH EXAMINER Executive Composite Score, J Int Neuropsychol Soc, 20, 20, 10.1017/S1355617713000611 · DOI · Paper page
  18. Hambleton RK, 1991, Fundamentals of Item Response Theory
  19. 10.1037/0894-4105.17.3.380 · DOI · Paper page
  20. 10.1212/WNL.0000000000002895 · DOI · Paper page
  21. 10.1007/s00415-018-8850-7 · DOI · Paper page
  22. 10.1017/S1355617712000823 · DOI
  23. 10.1017/S1355617714000551 · DOI · Paper page
  24. 10.1111/jnc.13654 · DOI · Paper page

Cited by

See all 47

Metadata

Authors
Staffaroni, A. M., Bajorek, L., Casaletto, K. B., Cobigo, Y., Goh, S. M., Wolf, A., Heuer, H. W., Elahi, F. M., Ljubenkov, P. A., Dever, R., Kornak, J., Appleby, B., Bove, J., Bordelon, Y., Brannelly, P., Brushaber, D., Caso, C., Coppola, G., Dheel, C., Dickerson, B. C., Dickinson, S., Dominguez, S., Domoto‐Reilly, K., Faber, K., Ferrall, J., Fields, J. A., Fishman, A., Fong, J., Foroud, T., Forsberg, L. K., Gavrilova, R., Gearhart, D., Ghazanfari, B., Ghoshal, N., Goldman, J., Graff‐Radford, J., Graff‐Radford, N., Grant, I., Grossman, M., Haley, D., Hsiung, G., Huey, E. D., Irwin, D. J., Jones, D. T., Jones, L., Kantarci, K., Karydas, A., Kaufer, D. I., Kerwin, D. R., Knopman, D. S., Kraft, R., Kremers, W. K., Kukull, W. A., Litvan, I., Lucente, D., Lungu, C., Mackenzie, I. R., Maldonado, M., Manoochehri, M., McGinnis, S. M., McKinley, E., Mendez, M. F., Miller, B. L., Multani, N., Onyike, C., Padmanabhan, J., Pantelyat, A., Pearlman, R., Petrucelli, L., Potter, M., Rademakers, R., Ramos, E. M., Rankin, K. P., Rascovsky, K., Roberson, E. D., Rogalski, E., Sengdy, P., Shaw, L. M., Syrjanen, J., Tartaglia, M. C., Tatton, N., Taylor, J., Toga, A., Trojanowski, J. Q., Weintraub, S., Wang, P., Wong, B., Wszolek, Z., Boxer, A. L., Boeve, B. F., Kramer, J. H., Rosen, H. J., & on behalf of the ARTFL/LEFFTDS consortium
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2020-01
Volume
16
Issue
1
Pages
11-21
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W2944460071
Cited by
47
References
9
FWCI
4.74
Type
journal article
Language
en
Open access
hybrid
Funders
  • National Institutes of Health (AG045390)
  • Larry L. Hillblom Foundation
  • Centers for Disease Control and Prevention
  • Bristol-Myers Squibb
  • Pfizer
  • Wyeth
  • Huntington's Disease Society of America
  • New York State Department of Health (1510130358)
  • Biogen
  • AbbVie
  • Canadian Institutes of Health Research
  • Alzheimer Society of B.C.
  • BrightFocus Foundation
  • Alzheimer's Drug Discovery Foundation
  • Roche
  • Genentech
  • Eisai
  • University of Southern California
  • AstraZeneca
  • U.S. Department of Defense
  • Parkinsonfonden
  • Michael J. Fox Foundation for Parkinson's Research
  • Janssen Pharmaceuticals
  • Merck
  • National Institute on Aging
  • National Institute of Neurological Disorders and Stroke
  • Allergan
  • Association for Frontotemporal Degeneration
  • Alzheimer's Association
  • GE Healthcare

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpoint. https://app.cochat.ai/papers/10.1016/j.jalz.2019.01.012
The paper
Staffaroni, A. M., Bajorek, L., Casaletto, K. B., Cobigo, Y., Goh, S. M., Wolf, A., Heuer, H. W., Elahi, F. M., Ljubenkov, P. A., Dever, R., Kornak, J., Appleby, B., Bove, J., Bordelon, Y., Brannelly, P., Brushaber, D., Caso, C., Coppola, G., Dheel, C., . . . on behalf of the ARTFL/LEFFTDS consortium. (2020). Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpoint. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2019.01.012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.